Eric Burton

961 total citations
26 papers, 605 citations indexed

About

Eric Burton is a scholar working on Oncology, Epidemiology and Genetics. According to data from OpenAlex, Eric Burton has authored 26 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Epidemiology and 5 papers in Genetics. Recurrent topics in Eric Burton's work include Viral-associated cancers and disorders (12 papers), Cytomegalovirus and herpesvirus research (7 papers) and Glioma Diagnosis and Treatment (4 papers). Eric Burton is often cited by papers focused on Viral-associated cancers and disorders (12 papers), Cytomegalovirus and herpesvirus research (7 papers) and Glioma Diagnosis and Treatment (4 papers). Eric Burton collaborates with scholars based in United States. Eric Burton's co-authors include Sumita Bhaduri‐McIntosh, Benjamin E. Gewurz, Michael Prados, Xiaofan Li, Sean K. Kelley, Jane Rabbitt, Raphaela Goldbach‐Mansky, Kathleen R. Lamborn, Mary Malec and Dong Xie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Eric Burton

26 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Burton United States 12 255 216 185 150 115 26 605
Chris A. Learn United States 7 311 1.2× 183 0.8× 162 0.9× 136 0.9× 209 1.8× 9 716
Carl Friedrich Classen Germany 17 114 0.4× 206 1.0× 120 0.6× 50 0.3× 54 0.5× 37 617
Mathieu Bourgey Canada 11 111 0.4× 334 1.5× 163 0.9× 42 0.3× 176 1.5× 19 806
Laure Vincent France 17 179 0.7× 439 2.0× 136 0.7× 32 0.2× 31 0.3× 58 802
Dan P. Hartmann United States 10 186 0.7× 134 0.6× 64 0.3× 40 0.3× 94 0.8× 12 543
Jean‐François Laes Belgium 12 146 0.6× 317 1.5× 31 0.2× 114 0.8× 71 0.6× 26 692
Paramjeet Singh India 12 275 1.1× 329 1.5× 43 0.2× 48 0.3× 83 0.7× 26 741
Daisy Alapat United States 14 152 0.6× 213 1.0× 114 0.6× 38 0.3× 262 2.3× 58 829
Benjamin E. Rich United States 15 151 0.6× 238 1.1× 98 0.5× 36 0.2× 77 0.7× 29 757
Chie Kobayashi Japan 13 59 0.2× 251 1.2× 69 0.4× 74 0.5× 48 0.4× 45 665

Countries citing papers authored by Eric Burton

Since Specialization
Citations

This map shows the geographic impact of Eric Burton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Burton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Burton more than expected).

Fields of papers citing papers by Eric Burton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Burton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Burton. The network helps show where Eric Burton may publish in the future.

Co-authorship network of co-authors of Eric Burton

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Burton. A scholar is included among the top collaborators of Eric Burton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Burton. Eric Burton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burton, Eric, et al.. (2025). Epstein-Barr virus latent membrane protein 1 subverts IMPDH pathways to drive B-cell oncometabolism. PLoS Pathogens. 21(5). e1013092–e1013092. 1 indexed citations
2.
Murray‐Nerger, Laura A., et al.. (2024). The nucleic acid binding protein SFPQ represses EBV lytic reactivation by promoting histone H1 expression. Nature Communications. 15(1). 4156–4156. 7 indexed citations
3.
Mitra, Bidisha, et al.. (2023). Characterization of target gene regulation by the two Epstein-Barr virus oncogene LMP1 domains essential for B-cell transformation. mBio. 14(6). e0233823–e0233823. 9 indexed citations
4.
Burton, Eric, et al.. (2022). Epstein–Barr virus latency programs dynamically sensitize B cells to ferroptosis. Proceedings of the National Academy of Sciences. 119(11). e2118300119–e2118300119. 50 indexed citations
5.
Burton, Eric & Benjamin E. Gewurz. (2022). Epstein–Barr virus oncoprotein–driven B cell metabolism remodeling. PLoS Pathogens. 18(2). e1010254–e1010254. 17 indexed citations
6.
King, Amanda, Dorela D. Shuboni‐Mulligan, Elizabeth Vera, et al.. (2022). Exploring the prevalence and burden of sleep disturbance in primary brain tumor patients. Neuro-Oncology Practice. 9(6). 526–535. 10 indexed citations
7.
Akinyemi, Ibukun A., et al.. (2021). An Ancestral Retrovirus Envelope Protein Regulates Persistent Gammaherpesvirus Lifecycles. Frontiers in Microbiology. 12. 708404–708404. 6 indexed citations
8.
Akinyemi, Ibukun A., Huanzhou Xu, Eric Burton, et al.. (2021). The danger molecule HMGB1 cooperates with the NLRP3 inflammasome to sustain expression of the EBV lytic switch protein in Burkitt lymphoma cells. Virology. 566. 136–142. 8 indexed citations
9.
Burton, Eric, Ibukun A. Akinyemi, Huanzhou Xu, et al.. (2021). A heterochromatin inducing protein differentially recognizes self versus foreign genomes. PLoS Pathogens. 17(3). e1009447–e1009447. 16 indexed citations
10.
Burton, Eric, Raphaela Goldbach‐Mansky, & Sumita Bhaduri‐McIntosh. (2020). A promiscuous inflammasome sparks replication of a common tumor virus. Proceedings of the National Academy of Sciences. 117(3). 1722–1730. 43 indexed citations
11.
McIntosh, Michael T., Siva Koganti, J. Lucas Boatwright, et al.. (2020). STAT3 imparts BRCAness by impairing homologous recombination repair in Epstein-Barr virus-transformed B lymphocytes. PLoS Pathogens. 16(10). e1008849–e1008849. 11 indexed citations
12.
Li, Xiaofan, Sandeepta Burgula, Ibukun A. Akinyemi, et al.. (2020). Nascent Transcriptomics Reveal Cellular Prolytic Factors Upregulated Upstream of the Latent-to-Lytic Switch Protein of Epstein-Barr Virus. Journal of Virology. 94(7). 12 indexed citations
13.
Xu, Huanzhou, Ramón Pérez, Eric Burton, et al.. (2019). Novel replisome-associated proteins at cellular replication forks in EBV-transformed B lymphocytes. PLoS Pathogens. 15(12). e1008228–e1008228. 14 indexed citations
14.
Li, Xiaofan, Eric Burton, Siva Koganti, et al.. (2018). KRAB-ZFP Repressors Enforce Quiescence of Oncogenic Human Herpesviruses. Journal of Virology. 92(14). 32 indexed citations
15.
Li, Xiaofan, Eric Burton, & Sumita Bhaduri‐McIntosh. (2017). Chloroquine triggers Epstein-Barr virus replication through phosphorylation of KAP1/TRIM28 in Burkitt lymphoma cells. PLoS Pathogens. 13(3). e1006249–e1006249. 56 indexed citations
16.
Prados, Michael D., Kathleen R. Lamborn, Susan M. Chang, et al.. (2006). Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma1. Neuro-Oncology. 8(1). 67–78. 172 indexed citations
17.
Burton, Eric & Michael Prados. (1999). New chemotherapy options for the treatment of malignant gliomas. Current Opinion in Oncology. 11(3). 157–157. 44 indexed citations
18.
Kubic, Virginia, et al.. (1995). Combined Superwarfarin and Ethylene Glycol Ingestion:A Unique Case Report With Misleading Clinical History. American Journal of Clinical Pathology. 104(6). 663–666. 4 indexed citations
19.
Seidel, Franziska, et al.. (1990). Cases of the day. Pediatric. Lipoblastoma.. Radiographics. 10(4). 728–731. 9 indexed citations
20.
Magill, H. Lynn, et al.. (1990). Case of the day. Pediatric. Idiopathic retroperitoneal fibrosis.. Radiographics. 10(6). 1096–1100. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chris A. Learn Breakdown of academic impact, for papers by Carl Friedrich Classen Breakdown of academic impact, for papers by Mathieu Bourgey Breakdown of academic impact, for papers by Laure Vincent Breakdown of academic impact, for papers by Dan P. Hartmann Breakdown of academic impact, for papers by Jean‐François Laes Breakdown of academic impact, for papers by Paramjeet Singh Breakdown of academic impact, for papers by Daisy Alapat Breakdown of academic impact, for papers by Benjamin E. Rich Breakdown of academic impact, for papers by Chie Kobayashi
Rankless by CCL
2026